Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in medicinal chemistry for constructing biologically active molecules due to the stability and conformational restraint provided by the cyclopropane ring. Also utilized in the preparation of fluorinated analogs to improve metabolic stability and bioavailability in drug candidates.